Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

De Laere B, Crippa A, Discacciati A, Larsson B, Persson M, Johansson S, D'hondt S, Bergström R, Chellappa V, Mayrhofer M, Banijamali M, Kotsalaynen A, Schelstraete C, Vanwelkenhuyzen JP, Hjälm-Eriksson M, Pettersson L, Ullén A, Lumen N, Enblad G, Thellenberg Karlsson C, Jänes E, Sandzén J, Schatteman P, Nyre Vigmostad M, Olsson M, Ghysel C, Sautois B, De Roock W, Van Bruwaene S, Anden M, Verbiene I, De Maeseneer D, Everaert E, Darras J, Aksnessether BY, Luyten D, Strijbos M, Mortezavi A, Oldenburg J, Ost P, Eklund M, Grönberg H, Lindberg J

Open source

DOI
10.1038/s41591-024-03268-0
Published
2024 Nov
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-024-03268-0,
  title = {Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.},
  author = {De Laere B and Crippa A and Discacciati A and Larsson B and Persson M and Johansson S and D'hondt S and Bergström R and Chellappa V and Mayrhofer M and Banijamali M and Kotsalaynen A and Schelstraete C and Vanwelkenhuyzen JP and Hjälm-Eriksson M and Pettersson L and Ullén A and Lumen N and Enblad G and Thellenberg Karlsson C and Jänes E and Sandzén J and Schatteman P and Nyre Vigmostad M and Olsson M and Ghysel C and Sautois B and De Roock W and Van Bruwaene S and Anden M and Verbiene I and De Maeseneer D and Everaert E and Darras J and Aksnessether BY and Luyten D and Strijbos M and Mortezavi A and Oldenburg J and Ost P and Eklund M and Grönberg H and Lindberg J},
  year = {2024},
  journal = {Nature medicine},
  doi = {10.1038/s41591-024-03268-0},
  url = {https://doi.org/10.1038/s41591-024-03268-0}
}

RIS

TY  - JOUR
TI  - Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.
AU  - De Laere B
AU  - Crippa A
AU  - Discacciati A
AU  - Larsson B
AU  - Persson M
AU  - Johansson S
AU  - D'hondt S
AU  - Bergström R
AU  - Chellappa V
AU  - Mayrhofer M
AU  - Banijamali M
AU  - Kotsalaynen A
AU  - Schelstraete C
AU  - Vanwelkenhuyzen JP
AU  - Hjälm-Eriksson M
AU  - Pettersson L
AU  - Ullén A
AU  - Lumen N
AU  - Enblad G
AU  - Thellenberg Karlsson C
AU  - Jänes E
AU  - Sandzén J
AU  - Schatteman P
AU  - Nyre Vigmostad M
AU  - Olsson M
AU  - Ghysel C
AU  - Sautois B
AU  - De Roock W
AU  - Van Bruwaene S
AU  - Anden M
AU  - Verbiene I
AU  - De Maeseneer D
AU  - Everaert E
AU  - Darras J
AU  - Aksnessether BY
AU  - Luyten D
AU  - Strijbos M
AU  - Mortezavi A
AU  - Oldenburg J
AU  - Ost P
AU  - Eklund M
AU  - Grönberg H
AU  - Lindberg J
PY  - 2024
JO  - Nature medicine
DO  - 10.1038/s41591-024-03268-0
UR  - https://doi.org/10.1038/s41591-024-03268-0
ER  -

APA

B, D. L., A, C., A, D., B, L., M, P., S, J., S, D., R, B., V, C., M, M., M, B., A, K., C, S., JP, V., M, H., L, P., A, U., N, L., G, E., C, T. K., E, J., J, S., P, S., M, N. V., M, O., C, G., B, S., W, D. R., S, V. B., M, A., I, V., D, D. M., E, E., J, D., BY, A., D, L., M, S., A, M., J, O., P, O., M, E., H, G., & J, L. (2024). Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.. Nature medicine. https://doi.org/10.1038/s41591-024-03268-0

Source records